Literature DB >> 31853384

Spectral indexes obtained by implementation of the fractional Fourier and Hermite transform for the diagnosis of malignant melanoma.

Esbanyely Garza-Flores1, Esperanza Guerra-Rosas2,3, Josué Álvarez-Borrego3.   

Abstract

Many people suffer from different skin diseases, which can be diverse and varied. Most skin diseases cause disorders in the skin, such as changes in color, texture, and appearance manifesting in spots, swelling, scaling, ulcers, etc. One of the diseases that represents a serious health problem is skin cancer. The most dangerous skin cancer is malignant melanoma, which can cause death if not detected early. Therefore, development of new and accurate diagnosis methodologies to increase the chance of early detection is important. In this work, an analysis to discriminate between malignant melanoma and three types of benign skin lesions-melanocytic nevus, dermatofibroma, and seborrheic keratosis-is realized by calculating spectral indexes based on the real and imaginary parts of a fractional nonlinear filter obtained by affecting the modulus of the fractional Fourier transform by an exponent k . The fractional spectral indexes were calculated by working with selected sub-images obtained by dividing the input image. Also, a variation was implemented when the Hermite transform is used to calculate the fractional nonlinear filter. Discrimination between malignant melanoma and benign skin lesions was achieved with a 99.7% confidence level.
© 2019 Optical Society of America under the terms of the OSA Open Access Publishing Agreement.

Entities:  

Year:  2019        PMID: 31853384      PMCID: PMC6913402          DOI: 10.1364/BOE.10.006043

Source DB:  PubMed          Journal:  Biomed Opt Express        ISSN: 2156-7085            Impact factor:   3.732


  14 in total

1.  Accuracy in the clinical diagnosis of malignant melanoma.

Authors:  C M Grin; A W Kopf; B Welkovich; R S Bart; M J Levenstein
Journal:  Arch Dermatol       Date:  1990-06

2.  Identification of melanoma cells: a method based in mean variance of signatures via spectral densities.

Authors:  Esperanza Guerra-Rosas; Josué Álvarez-Borrego; Aracely Angulo-Molina
Journal:  Biomed Opt Express       Date:  2017-03-15       Impact factor: 3.732

3.  Dermatofibroma: a curious tumor.

Authors:  Lawrence Charles Parish; Shideh Yazdanian; W Clark Lambert; Peter C Lambert
Journal:  Skinmed       Date:  2012 Sep-Oct

Review 4.  Computerized analysis of pigmented skin lesions: a review.

Authors:  Konstantin Korotkov; Rafael Garcia
Journal:  Artif Intell Med       Date:  2012-10-11       Impact factor: 5.326

5.  Melanomas non-invasive diagnosis application based on the ABCD rule and pattern recognition image processing algorithms.

Authors:  A Gola Isasi; B García Zapirain; A Méndez Zorrilla
Journal:  Comput Biol Med       Date:  2011-07-20       Impact factor: 4.589

6.  Melanoma: accuracy of clinical diagnosis.

Authors:  A R MacKenzie-Wood; G W Milton; J W de Launey
Journal:  Australas J Dermatol       Date:  1998-02       Impact factor: 2.875

7.  Accuracy in the clinical diagnosis and pattern of malignant melanoma at a dermatological clinic.

Authors:  B Lindelöf; M A Hedblad
Journal:  J Dermatol       Date:  1994-07       Impact factor: 4.005

8.  Methodology for diagnosing of skin cancer on images of dermatologic spots by spectral analysis.

Authors:  Esperanza Guerra-Rosas; Josué Álvarez-Borrego
Journal:  Biomed Opt Express       Date:  2015-09-09       Impact factor: 3.732

9.  Accuracy of Skin Cancer Diagnosis by Physician Assistants Compared With Dermatologists in a Large Health Care System.

Authors:  Alyce M Anderson; Martha Matsumoto; Melissa I Saul; Aaron M Secrest; Laura K Ferris
Journal:  JAMA Dermatol       Date:  2018-05-01       Impact factor: 10.282

10.  Mechanical properties of growing melanocytic nevi and the progression to melanoma.

Authors:  Alessandro Taloni; Alexander A Alemi; Emilio Ciusani; James P Sethna; Stefano Zapperi; Caterina A M La Porta
Journal:  PLoS One       Date:  2014-04-07       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.